176 related articles for article (PubMed ID: 2457192)
1. Weekly intramuscular methotrexate for nonmetastatic gestational trophoblastic disease.
Homesley HD; Blessing JA; Rettenmaier M; Capizzi RL; Major FJ; Twiggs LB
Obstet Gynecol; 1988 Sep; 72(3 Pt 1):413-8. PubMed ID: 2457192
[TBL] [Abstract][Full Text] [Related]
2. Development of single-agent chemotherapy regimens for gestational trophoblastic disease.
Homesley HD
J Reprod Med; 1994 Mar; 39(3):185-92. PubMed ID: 7518517
[TBL] [Abstract][Full Text] [Related]
3. A single institution experience with weekly intramuscular methotrexate for nonmetastatic gestational trophoblastic disease.
Hoffman MS; Fiorica JV; Gleeson NC; Roberts WS; Cavanagh D
Gynecol Oncol; 1996 Feb; 60(2):292-4. PubMed ID: 8631554
[TBL] [Abstract][Full Text] [Related]
4. Weekly intravenous methotrexate with folinic acid for nonmetastatic gestational trophoblastic neoplasia.
Kwon JS; Elit L; Mazurka J; Moens F; Schmuck ML
Gynecol Oncol; 2001 Aug; 82(2):367-70. PubMed ID: 11531296
[TBL] [Abstract][Full Text] [Related]
5. High-dose methotrexate for gestational trophoblastic disease.
Elit L; Covens A; Osborne R; Gerulath A; Murphy J; Rosen B; Sturgeon J
Gynecol Oncol; 1994 Sep; 54(3):282-7. PubMed ID: 7522198
[TBL] [Abstract][Full Text] [Related]
6. Weekly intramuscular methotrexate in the treatment of low-risk gestational trophoblastic neoplasia.
Mohit M; Sarraf Z; Sheikhi G; Robati M; Vasheghani-Farahani A
Arch Gynecol Obstet; 2009 Nov; 280(5):775-80. PubMed ID: 19263063
[TBL] [Abstract][Full Text] [Related]
7. Rapid escalation of weekly intramuscular methotrexate for nonmetastatic gestational trophoblastic disease: a Gynecologic Oncology Group study.
Homesley HD; Blessing JA; Schlaerth J; Rettenmaier M; Major FJ
Gynecol Oncol; 1990 Dec; 39(3):305-8. PubMed ID: 2175286
[TBL] [Abstract][Full Text] [Related]
8. Nonmetastatic gestational trophoblastic disease. Weekly methotrexate compared with 8-day methotrexate-folinic acid.
Gleeson NC; Finan MA; Fiorica JV; Robert WS; Hoffman MS; Wilson J
Eur J Gynaecol Oncol; 1993; 14(6):461-5. PubMed ID: 7514124
[TBL] [Abstract][Full Text] [Related]
9. 5-day methotrexate for women with metastatic gestational trophoblastic disease.
Soper JT; Clarke-Pearson DL; Berchuck A; Rodriguez G; Hammond CB
Gynecol Oncol; 1994 Jul; 54(1):76-9. PubMed ID: 8020843
[TBL] [Abstract][Full Text] [Related]
10. Single-agent chemotherapy for nonmetastatic gestational trophoblastic neoplasia. Perspectives for the 21st century after three decades of use.
Kohorn EI
J Reprod Med; 1991 Jan; 36(1):49-55. PubMed ID: 1848901
[TBL] [Abstract][Full Text] [Related]
11. Methotrexate with citrovorum factor rescue for nonmetastatic gestational trophoblastic neoplasms.
Goldstein DP; Goldstein PR; Bottomley P; Osathanondh R; Marean AR
Obstet Gynecol; 1976 Sep; 48(3):321-3. PubMed ID: 181702
[TBL] [Abstract][Full Text] [Related]
12. Treatment of nonmetastatic gestational trophoblastic disease with sequential intramuscular and oral methotrexate.
Barter JF; Soong SJ; Hatch KD; Orr JW; Partridge EC; Austin JM; Shingleton HM
Gynecol Oncol; 1989 Apr; 33(1):82-4. PubMed ID: 2467846
[TBL] [Abstract][Full Text] [Related]
13. Phase II trial of pulse dactinomycin as salvage therapy for failed low-risk gestational trophoblastic neoplasia: a Gynecologic Oncology Group study.
Covens A; Filiaci VL; Burger RA; Osborne R; Chen MD;
Cancer; 2006 Sep; 107(6):1280-6. PubMed ID: 16900525
[TBL] [Abstract][Full Text] [Related]
14. Medium-dose methrotrexate/folinic acid regimen in the chemotherapy of gestational trophoblastic disease.
Khoo SK; Jones IS
Med J Aust; 1980 Apr; 1(7):317-20. PubMed ID: 6248746
[TBL] [Abstract][Full Text] [Related]
15. Alternating weekly chemotherapy with etoposide-methotrexate-dactinomycin/cyclophosphamide-vincristine for high-risk gestational trophoblastic disease.
Soper JT; Evans AC; Clarke-Pearson DL; Berchuck A; Rodriguez G; Hammond CB
Obstet Gynecol; 1994 Jan; 83(1):113-7. PubMed ID: 8272290
[TBL] [Abstract][Full Text] [Related]
16. Single-dose actinomycin-D treatment for nonmetastatic gestational trophoblastic disease. A prospective phase II trial of the Gynecologic Oncology Group.
Petrilli ES; Twiggs LB; Blessing JA; Teng NH; Curry S
Cancer; 1987 Nov; 60(9):2173-6. PubMed ID: 2449942
[TBL] [Abstract][Full Text] [Related]
17. High-risk metastatic gestational trophoblastic disease.
Gordon AN; Gershenson DM; Copeland LJ; Saul PB; Kavanagh JJ; Edwards CL
Obstet Gynecol; 1985 Apr; 65(4):550-6. PubMed ID: 2580255
[TBL] [Abstract][Full Text] [Related]
18. [The kinetics of chorionic gonadotropin and its subunits in normal pregnancy and gestational trophoblastic neoplasms].
Kunhardt J; Calderón J; Rodríguez S; Fletcher P; Ayala A; Reyes V
Ginecol Obstet Mex; 1987 Jul; 55():188-91. PubMed ID: 2484840
[No Abstract] [Full Text] [Related]
19. A prospective randomized comparison of methotrexate, dactinomycin, and chlorambucil versus methotrexate, dactinomycin, cyclophosphamide, doxorubicin, melphalan, hydroxyurea, and vincristine in "poor prognosis" metastatic gestational trophoblastic disease: a Gynecologic Oncology Group study.
Curry SL; Blessing JA; DiSaia PJ; Soper JT; Twiggs LB
Obstet Gynecol; 1989 Mar; 73(3 Pt 1):357-62. PubMed ID: 2536911
[TBL] [Abstract][Full Text] [Related]
20. Phase I trial of methotrexate-albumin in a weekly intravenous bolus regimen in cancer patients. Phase I Study Group of the Association for Medical Oncology of the German Cancer Society.
Hartung G; Stehle G; Sinn H; Wunder A; Schrenk HH; Heeger S; Kränzle M; Edler L; Frei E; Fiebig HH; Heene DL; Maier-Borst W; Queisser W
Clin Cancer Res; 1999 Apr; 5(4):753-9. PubMed ID: 10213209
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]